It is likely that CD226 drives pathogenicity in both cell types, and further interrogation of CD4+ T cell phenotype in the CD226 KO mouse may uncover mechanisms by which CD226 expression on CD4+ T cells contributes to type 1 diabetes. This evidence concerns the gene CD226 and type 1 diabetes mellitus.